279 related articles for article (PubMed ID: 28688616)
1. Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates.
Bobály B; Fleury-Souverain S; Beck A; Veuthey JL; Guillarme D; Fekete S
J Pharm Biomed Anal; 2018 Jan; 147():493-505. PubMed ID: 28688616
[TBL] [Abstract][Full Text] [Related]
2. Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs.
Chapel S; Rouvière F; Sarrut M; Heinisch S
Methods Mol Biol; 2020; 2078():163-185. PubMed ID: 31643056
[TBL] [Abstract][Full Text] [Related]
3. Hydrophobic interaction chromatography for the characterization of monoclonal antibodies and related products.
Fekete S; Veuthey JL; Beck A; Guillarme D
J Pharm Biomed Anal; 2016 Oct; 130():3-18. PubMed ID: 27084526
[TBL] [Abstract][Full Text] [Related]
4. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
[TBL] [Abstract][Full Text] [Related]
5. Is hydrophobic interaction chromatography the most suitable technique to characterize site-specific antibody-drug conjugates?
D'Atri V; Pell R; Clarke A; Guillarme D; Fekete S
J Chromatogr A; 2019 Feb; 1586():149-153. PubMed ID: 30554777
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs).
Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W
J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625
[TBL] [Abstract][Full Text] [Related]
7. Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography.
Ouyang J
Methods Mol Biol; 2013; 1045():275-83. PubMed ID: 23913154
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions.
Sarrut M; Corgier A; Fekete S; Guillarme D; Lascoux D; Janin-Bussat MC; Beck A; Heinisch S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():103-111. PubMed ID: 27426266
[TBL] [Abstract][Full Text] [Related]
9. Characterization of drug load variants in a thiol linked antibody-drug conjugate using multidimensional chromatography.
Gilroy JJ; Eakin CM
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():182-189. PubMed ID: 28622622
[TBL] [Abstract][Full Text] [Related]
10. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148
[TBL] [Abstract][Full Text] [Related]
11. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
Friese OV; Smith JN; Brown PW; Rouse JC
MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
[TBL] [Abstract][Full Text] [Related]
12. Impact of linker-drug on ion exchange chromatography separation of antibody-drug conjugates.
Zhang Z; Zhou S; Han L; Zhang Q; Pritts WA
MAbs; 2019; 11(6):1113-1121. PubMed ID: 31238787
[TBL] [Abstract][Full Text] [Related]
13. Computer assisted liquid chromatographic method development for the separation of therapeutic proteins.
Tyteca E; Veuthey JL; Desmet G; Guillarme D; Fekete S
Analyst; 2016 Oct; 141(19):5488-501. PubMed ID: 27545865
[TBL] [Abstract][Full Text] [Related]
14. Analysis of ADCs by Native Mass Spectrometry.
Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
[TBL] [Abstract][Full Text] [Related]
15. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
Yan Y; Xing T; Wang S; Daly TJ; Li N
J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
[TBL] [Abstract][Full Text] [Related]
16. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD
MAbs; 2016; 8(4):698-705. PubMed ID: 26891281
[TBL] [Abstract][Full Text] [Related]
17. Investigation of low recovery in the free drug assay for antibody drug conjugates by size exclusion-reversed phase two dimensional-liquid chromatography.
Li Y; Stella C; Zheng L; Bechtel C; Gruenhagen J; Jacobson F; Medley CD
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():112-118. PubMed ID: 27212187
[TBL] [Abstract][Full Text] [Related]
18. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug species.
Sarrut M; Fekete S; Janin-Bussat MC; Colas O; Guillarme D; Beck A; Heinisch S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():91-102. PubMed ID: 27426265
[TBL] [Abstract][Full Text] [Related]
19. A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.
Deslignière E; Diemer H; Erb S; Coliat P; Pivot X; Detappe A; Hernandez-Alba O; Cianférani S
Front Biosci (Landmark Ed); 2022 Oct; 27(10):290. PubMed ID: 36336868
[TBL] [Abstract][Full Text] [Related]
20. Native Reversed-Phase Liquid Chromatography: A Technique for LCMS of Intact Antibody-Drug Conjugates.
Chen TH; Yang Y; Zhang Z; Fu C; Zhang Q; Williams JD; Wirth MJ
Anal Chem; 2019 Feb; 91(4):2805-2812. PubMed ID: 30661356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
